Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

VNDA

Vanda Pharmaceuticals Inc

Jun 09 • 04:00PM ET

6.12

+0.18 3.03 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NKTR KROS VKTX BMRN INCY RYTM AXSM MDGL KRYS NBIX

| Held by: VTI XBI IWM VXF IWN IBB VTWO SCHA VFMO DFMC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.05	Insider Own	5.51%	Shs Outstand	60.14M	Perf Week	-0.16%
Market Cap	368.03M	Forward P/E	-	EPS next Y	-0.87	Insider Trans	-9.41%	Shs Float	56.82M	Perf Month	-2.55%
Enterprise Value	178.79M	PEG	-	EPS next Q	-0.60	Inst Own	77.40%	Short Float	11.99%	Perf Quarter	-35.98%
Income	-239.55M	P/S	1.69	EPS this Y	38.45%	Inst Trans	6.86%	Short Ratio	4.90	Perf Half Y	13.54%
Sales	217.78M	P/B	1.31	EPS next Y	62.03%	ROA	-44.97%	Short Interest	6.81M	Perf YTD	-30.61%
Book/sh	4.67	P/C	1.82	EPS next 5Y	45.07%	ROE	-60.48%	52W High	9.94 -38.43%	Perf Year	33.33%
Cash/sh	3.36	P/FCF	-	EPS past 3/5Y	- -	ROIC	-83.23%	52W Low	4.14 47.83%	Perf 3Y	-5.85%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-5.29% -2.73%	Gross Margin	89.91%	Volatility	4.00% 3.88%	Perf 5Y	-67.34%
Dividend TTM	-	EV/Sales	0.82	EPS Y/Y TTM	-434.76%	Oper. Margin	-73.64%	ATR (14)	0.28	Perf 10Y	-44.29%
Dividend Ex-Date	-	Quick Ratio	2.15	Sales Y/Y TTM	8.16%	Profit Margin	-109.99%	RSI (14)	43.01	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	2.16	EPS Q/Q	-62.10%	SMA20	-1.97%	Beta	0.61	Target Price	14.90
Payout	-	Debt/Eq	0.05	Sales Q/Q	3.35%	SMA50	-8.72%	Rel Volume	0.59	Prev Close	5.94
Employees	533	LT Debt/Eq	0.03	Earnings	May 06 AMC	SMA200	-3.64%	Avg Volume	1.39M	Price	6.12
IPO	Apr 12, 2006	Option/Short	Yes / Yes	EPS/Sales Surpr.	-19.19% -5.93%	Trades		Volume	823,613	Change	3.03%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)